TSP-2 exerted anti-fibrotic effects in experimental acute renal disease [15], [38], myocarditis [16] and age-related cardiomyopathy [17], but displayed profibrotic properties in other diseases like scleroderma [45] or in cardiac cell grafts [46]. This evidence concerns the gene THBS2 and scleroderma.